Rac1 is a member of the Ras superfamily of small GTPases involved in signal transduction pathways that induce the formation of lamellipodia, stimulate cell proliferation and activate the JNK/SAPK protein kinase cascade. Here we describe that ampli®cation by RT ± PCR of the entire Rac1 coding sequence from a series of human adult and fetal tissues revealed beside the expected Rac1 cDNA, a variant product which contained additional 57 nucleotides between codons 75 and 76. This variant resulted in an in-frame insertion of 19 new amino acids immediately behind the switch II region, including two potential threonine phosphorylation sites for casein kinase II and protein kinase C. Primers designed within and downstream of the inserted nucleotide sequence allowed isolation of a genomic clone with intronic consensus sequences demonstrating that the insertion corresponds to a novel, yet undescribed exon 3b. This Rac1 splice variant, designated Rac1b, was predominantly identi®ed in skin and epithelial tissues from the intestinal tract. Most notably, the expression of rac1b versus rac1 was found to be elevated in colorectal tumors at various stages of neoplastic progression, as compared to their respective adjacent tissues. We suggest that the 19 amino acid-insertion following the switch II region may create a novel eector binding site in rac1b, and thus participate in signaling pathways related to the normal or neoplastic growth of the intestinal mucosa.
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Keywords: Rac1; Ras; GTPase; colorectal cancer; alternative splicing Small GTPases of the Ras-superfamily function as molecular switches in important cellular processes including signal transduction, vesicle tracking and nuclear protein import (Macara et al., 1996) . The archetype of these GTPases is the proto-oncogene Ras that relays activation of receptor and non-receptor tyrosine kinases to the transcription of target genes involved in cell proliferation and neoplastic transformation. These small GTPases are regulated through a cycle of GDP/GTP exchange in which binding of GTP induces a conformational change, bringing together two regions called switch I (residues 30 ± 37 in Ras) and switch II (residues 60 ± 76 in Ras) (reviewed in Wittinghofer and Nassar, 1996) . This enables the GTPases to activate downstream eectors until their intrinsic GTPase activity terminates this interaction. The regulation of this switch function is, however, mainly controlled by either activating guanine nucleotide exchange factors (GEF) or inactivating GTPase activating factors (GAP).
One subfamily, the Rho-GTPases, has numerous members including Rho, Rac and Cdc42 that were initially described as regulators of the organization of the actin cytoskeleton (Hall, 1994; Nobes and Hall, 1995) . Rho was reported to regulate stress ®ber and focal adhesion formation whereas Rac and Cdc42 induced formation of lamellipodia or membrane ruing and ®lopodia, respectively.
Subsequently, a more complex picture on their involvement in signal transduction evolved when the eect of constitutively active mutant cDNAs were studied. The activating target codons 12 or 61 were initially identi®ed in retroviral v-Ras oncogenes and shown to destroy its GTPase activity (Schezek et al., 1997) . The conservation of these codons in the Rho-family members allowed site-directed mutagenesis to create constitutively active forms. These new tools contributed much to the current picture on Rho, Rac and Cdc42-dependent signaling (see Zohn et al., 1998 for a recent review). In the case of Rac1, cultured cells were transfected with constitutively active mutants and revealed three cellular functions: ®rst, the formation of lamellipodia (Ridley et al., 1992) , re¯ecting a re-organization of actin ®laments; second, the progression through the G1 phase of the cell cycle followed by DNA replication (Olson et al., 1995; Moore et al., 1997) ; and third, the activation of the JNK/SAPK protein kinase cascade (Minden et al., 1995; Coso et al., 1995; At® et al., 1997) , leading to phosphorylation and activation of transcription factors, e.g. c-jun.
More recently, physiological processes that activate Rac1 have been described, one of which is cell adhesion. Rac1-mediated signaling was found to be involved in the regulation of tight junctions (Jou et al., 1998b) , cadherin-mediated cell ± cell adhesion (Takaishi et al., 1997; Braga et al., 1997; Jou and Nelson, 1998a; Kuroda et al., 1998) and integrin-mediated cell ± matrix adhesion (Hotchin and Hall, 1995; Allen et al., 1997; Machesky and Hall, 1997; Miranti et al., 1998; Price et al., 1998) . Rac1 therefore appears to act on the equilibrium between cell adhesion and cell motility, the deregulation of which will disrupt epithelial and mucosal integrity. Indeed, the activation of either Rac1 (Anand-Apte et al., 1997; Keely et al., 1997; Shaw et al., 1997; Klemke et al., 1998) or Rac-speci®c GEFs (Michiels et al., 1995; Hordijk et al., 1997) are involved in the invasive phenotype, the motile component being represented by the formation of lamellipodia.
The digestive tract appears particularly sensitive to genetic alterations that aect the regulation of cell adhesion. Colorectal cancer, for instance, is characterized by molecular defects in the Wnt/APC/b-catenin pathways (reviewed in Kinzler and Vogelstein, 1996; Vider et al., 1996; Morin et al., 1997) , whereas gastric cancer can be inherited by mutations in the E-cadherin gene (Guilford et al., 1998; Gather et al., 1998) . We were therefore interested to study the involvement of Rac1 signaling in this process.
As a ®rst step, the expression pro®le of human Rac1 was studied by RT ± PCR in various adult and fetal tissues. Total RNA was reverse transcribed using oligodT primers and then ampli®ed with primers directed to the 5'-and 3'-untranslated regions of Rac1. In these regions the sequence is dierent for the three family members Rac1, Rac2 and Rac3, thus allowing speci®c ampli®cation of Rac1. When the RT ± PCR products were separated by agarose gel electrophoresis, the expected 600 bp product of the Rac1 cDNA was detected in all samples (see Figure 1 ). In addition, a second product of 720 bp was detected in some tissues, with strongest expression in adult colon mucosa and colon crypt epithelial cells as well as in fetal samples from colon, small intestine and skin. Weak expression was detected in liver, pancreas, placenta and spleen, whereas the product was absent from fetal brain, fetal heart, and macrophages. The 720 bp product was still ampli®ed when the annealing temperature of the PCR reaction was raised to 688C, indicating that amplification was speci®c. No ampli®cation was obtained when RNA was mock reverse transcribed without adding reverse transcriptase, demonstrating that ampli®cation was not due to contaminating genomic DNA.
To investigate the molecular identity of the 720 bpRac1 PCR product, the PCR products ampli®ed from fetal colon were subcloned using the TA-cloning technique (Invitrogen) and used to transform bacteria. Positive colonies that contained either the subcloned 660 or the 720 bp product were grown for minipreparation and sequencing of the corresponding plasmids. Both subcloned PCR products were found to be identical to Rac1. However, the larger 720 bp product contained an additional 57 nucleotides (nt) inserted between codons 75 and 76, i.e. at nt 226 of the Rac1-coding sequence. When translated into protein sequence this insertion corresponded to an in-frame addition of 19 new amino acids, unrelated to any known sequence in the currently available databases. We then repeated the whole subcloning procedure for the two PCR products ampli®ed from human fetal skin and obtained exactly the same result. The alignment of the Rac1 and Rac-variant protein sequences is shown in Figure 2 .
The origin of the inserted variant sequence remained unclear. One possible explanation was that the insertion re¯ected a somatic recombination event.
Since tissue samples from dierent nonpathologic individuals were used in our RT ± PCR analysis this possibility appeared unlikely. Another possibility was that the variant Rac1 cDNA was the result of an alternative splicing event. In this case, the inserted 57 nt-sequence should correspond to an additional exon. This possibility could not be veri®ed directly because the sequence and organization of the Rac1 gene is still unknown. However, the structure of the Rac2 gene was recently published (Courjal et al., 1997) . Rac2 is a very close homolog of Rac1 that is speci®cally expressed in hematopoietic cells. Both Rac1 and Rac2 cDNAs share 92% amino acid identity. It was therefore likely that the basic exon/intron architecture of both genes was evolutionary conserved. With this assumption, we analysed the Rac2 gene with respect to the site of insertion of the Rac1 variant sequence. Interestingly, the insertion site between codons 75 and 76 corresponded exactly to the exon 3/exon 4 splice junction in Rac2.
The fact that the site of insertion in the Rac1-variant corresponded exactly to an exon splice junction encouraged us to test experimentally whether an additional, new exon 3b could be demonstrated. To this end we designed primers within the inserted variant sequence, and in the two putative¯anking exons 3 and 4 in order to amplify by PCR the Figure 1 Ethidium bromide stained agarose gel showing Rac1 RT ± PCR products from various human tissues. Total RNA (4 mg) was reverse transcribed with oligo-dT primers followed by ampli®cation of Rac1 using the primers rac5utr (5'-ttcctatctcagcgccctgcc) and rac3utr (5'-ggacaggaccaagaacgaggg) in 30 cycles of 948C-30 s, 648C-1 min, 728C-1 min. Tissues, as indicated in the Figure, were: colon crypt epithelial cells; fetal colon and small intestine; adult colon mucosa, liver and macrophages; fetal skin, pancreas, liver, heart, adrenals, spleen and brain. Note beside the expected 660 bp Rac1 product, the second speci®c product of 720 bp in some tissues expected portion of the Rac1 gene. Genomic DNA was isolated from peripheral blood lymphocytes and ampli®ed with primer pairs exon 3b-forward/exon 4-reverse and exon 3-forward/exon 3b-reverse. The primer pair exon 3-forward/exon 3b-reverse ampli®ed a weak 45 kb product that could not yet be further analysed. In contrast, the primer pair exon 3b-forward/exon 4-reverse ampli®ed a single 1.5 kb product which was subcloned and completely sequenced. As shown in Figure 3 , this product contained a non-coding sequence that was¯anked at both ends by the expected coding sequences of exons 3b and 4, respectively. This non-coding sequence started at its 5'-end with the motif`GTAT', a splice donor consensus sequence (Schneider, 1997) , and ended at the 3'-end with the motif`TAG', a splice acceptor consensus sequence. The latter motif was preceeded by a clear poly-pyrimidine tract.
From these sequence data we conclude that we ampli®ed a part of the human Rac1 gene corresponding to intron 3b (EMBL database accession number: AJ132695). We further conclude that the variant Rac1 cDNA (EMBL database accession number: AJ132694), that we propose to term Rac1b, is a splice variant that retains a novel, yet undescribed exon 3b. Alternative splicing of pre-messenger RNA is a common phenomenon mediated by the interaction of RNA-binding proteins with speci®c splice site recognition elements (reviewed by Chabot, 1996; Cooper and Mattox, 1997) . The extent of alternative splicing of a given transcript is thought to re¯ect the tissue-speci®c expression pro®le of such RNA-binding proteins.
The amino acid insertion in Rac1b is located immediately behind the so-called switch II region (residues 60 ± 76, see Ihara et al., 1998 for a recent alignment). The conformational change that accompanies the transition from the inactive GDP-to the active GTP-bound form is mediated by a change in position of the switch I and switch II regions. Both regions also contribute to the contact regions between the GTPases and some eectors like GAPs, as demonstrated by X-ray data on crystallized GTPase/ GAP complexes for Ras, RhoA and Cdc42 (Schezek et al., 1997; Rittinger et al., 1997; Nassar et al., 1998) . The Ras-related GTPases show a common structure of a six-stranded b-sheet, connected by loops to surrounding helices. The segment between b-strands B3 and B4 contains the switch II region including the key catalytic residue Q61. The Rac1b insertion is located between the loop L5-sequence 71 SYPQT 75 (which marks the end of the switch II region) and the sequence 77 
VFLICFS
83 that constitutes the B4-strand (Hirshberg et al., 1997; Ihara et al., 1998) and that coincides with the beginning of exon 4 (see Figure  3) . The insertion of 19 additional amino acids at this position might represent a new functional domain. Molecular modeling suggests that the insert is made out of two beta strands connected by a turn. Its mainly polar/charged character would make it stable as an exposed sub-domain (M Hirshberg, personal communication). Whether its interaction with GAPs is maintained or whether the Rac1b insert creates a yet unknown eector binding site cannot be directly deduced from the currently available data. In addition, the amino acid insertion creates two potential threonine phosphorylation sites for casein kinase II ( 75 TVGE) and protein kinase C ( 85 TSR). Whether phosphorylation of these sites occurs and could aect Rac1b's molecular¯exibility or function is another interesting aspect to study.
It appears, however, very likely that Rac1b will not dier from Rac1 with respect to its intrinsic GTPase activity. Both forms are also identical with respect to the C-terminal geranyl-geranylation motif CLLL that confers plasma membrane anchorage (Kinsella et al., 1991) , as well as the hydrophobic and polybasic motif recently identi®ed to mediate interaction with lipid products of PI3-kinase (Missy et al., 1998) .
The expression pro®le of Rac1b shown in Figure 1 revealed strong prevalence in colon-derived samples. We therefore wondered whether Rac1b expression might be of any signi®cance for the characterization of human colorectal tumors including progression towards metastasis. Thirteen specimens of colon adenocarcinomas (ADK) of dierent stages from eight male and ®ve female patients (mean age 61 years) as well as six liver metastases from ®ve male and one female patients (mean age 69 years) were analysed. Total RNA from these sporadic tumors and metastases, and their respective control tissues were analysed by RT ± PCR for Rac1 and Rac1b expression. Gel electrophoresis analysis revealed a comparable expression of Rac1 in the tumors when compared to the control tissues. A typical result is shown in Figure 4 , representative of two samples out of two adenocarcinomas with Duke's grade A (2/2 ADK A), 2/6 ADK B, 3/4 ADK C2, 1/1 ADK D, 6/6 liver metastases. These RT ± PCR show that the ratio of expression of Rac1b versus Rac1 appears increased in colorectal tumors as compared to their respective adjacent control tissues. This makes Rac1b a very interesting candidate for further studies on its expression and involvement in colorectal tumorigenesis.
In summary, we describe Rac1b, a variant Rac1 cDNA that originates from alternative splicing leading to an in-frame inclusion of a yet undescribed exon 3b. This Rac1b variant is expressed beside Rac1 in most epithelial tissues and in colorectal tumors at various stages of neoplastic progressin. Future work will now have to clarify whether Rac1b has any prognostic value for monitoring colorectal cancer patients. In addition, studies focusing on the ectopoic expression of Rac1b in cell lines will show whether the 19 additional amino acids participate as an eector binding domain in signaling pathways, e.g. from cell adhesion molecules. This should provide more information about the functional role of this Rac1-variant in normal and neoplastic growth of the colorectal mucosa.
Note added in proof To our knowledge, this is the ®rst demonstration of alternative splicing in the Rho-family of GTPases. 
